|
⚲
|
| Keyboard |
| Nancy Stagliano | |
|---|---|
| Firm | |
| Address | c/o Star Therapeutics LLC 201 Haskins Way, 5th Floor South San Francisco, CA 94080 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Star Therapeutics LLC | 021-559890 | Director | 125.0 M of 125.0 M |
||
| Latigo Biotherapeutics Inc | 021-538236 | Director | 50.0 M of 150.0 M |
||
| Pandion Therapeutics HoldCo LLC | 021-364484 | Director | 40.0 M of 80.0 M |
||
| Bioasis Technologies Inc | 021-313471 | Director | 0.7 M of 0.7 M |
||
| CytomX Therapeutics Inc | 021-148281 | Executive Officer | 2.7 M of 2.7 M |
||
| CytomX Therapeutics Inc | 021-148280 | Executive Officer | 10.0 M of 30.0 M |
||
| CytomX Therapeutics Inc | 021-148274 | Executive Officer | 0.5 M of 0.5 M |
||
| CytomX Therapeutics Inc | 021-148277 | Executive Officer | 0.1 M of 0.1 M |
||
| CytomX Therapeutics Inc | 021-148279 | Executive Officer | 0.7 M of 0.7 M |
||
| CytomX Therapeutics LLC | 021-148112 | Executive Officer | 2.7 M of 2.7 M |
||
| CytomX Therapeutics LLC | 021-131732 | Executive Officer | 2.5 M of 2.5 M |
||